Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 2, 2010, Pages 132-139

  Luong, Me Linh ^a,b   Filion, Charles ^b   Labbé, Annie Claude ^b   Roy, Jean ^b   Pépin, Jacques ^c   Cadrin Tourigny, Julia ^b   Carignan, Stéphane ^b   Sheppard, Donald C ^a   Laverdière, Michel ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Aspergillosis; Bronchoalveolar lavage; Galactomannan; Hematologic malignancies

Indexed keywords

GALACTOMANNAN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG ASPERGILLOSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ANTIGENS, FUNGAL; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CANADA; COHORT STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOENZYME TECHNIQUES; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; OPPORTUNISTIC INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77956567067     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.03.017     Document Type: Article

References (28)

1. Bart-Delabesse E., Basile M., Al Jijakli A., Souville D., Gay F., Philippe B., Bossi P., Danis M., Vernant J.P., Datry A. Detection of aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J. Clin. Microbiol. 2005, 43:5214-5220.
2. Becker M.J., Lugtenburg E.J., Cornelissen J.J., Van Der Schee C., Hoogsteden H.C., De Marie S. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br. J. Haematol. 2003, 121:448-457.
3. Buckingham S.J., Hansell D.M. Aspergillus in the lung: diverse and coincident forms. Eur. Radiol. 2003, 13:1786-1800.
4. Clancy C.J., Jaber R.A., Leather H.L., Wingard J.R., Staley B., Wheat L.J., Cline C.L., Rand K.H., Schain D., Baz M., Nguyen M.H. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J. Clin. Microbiol. 2007, 45:1759-1765.
5. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., Pappas P.G., Maertens J., Lortholary O., Kauffman C.A., Denning D.W., Patterson T.F., Maschmeyer G., Bille J., Dismukes W.E., Herbrecht R., Hope W.W., Kibbler C.C., Kullberg B.J., Marr K.A., Munoz P., Odds F.C., Perfect J.R., Restrepo A., Ruhnke M., Segal B.H., Sobel J.D., Sorrell T.C., Viscoli C., Wingard J.R., Zaoutis T., Bennett J.E. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 2008, 46:1813-1821.
6. Denning D.W., Evans E.G., Kibbler C.C., Richardson M.D., Roberts M.M., Rogers T.R., Warnock D.W., Warren R.E. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur. J. Clin. Microbiol. Infect. Dis. 1997, 16:424-436.
7. Fukuda T., Boeckh M., Carter R.A., Sandmaier B.M., Maris M.B., Maloney D.G., Martin P.J., Storb R.F., Marr K.A. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003, 102:827-833.
8. Garcia-Vidal C., Upton A., Kirby K.A., Marr K.A. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin. Infect. Dis. 2008, 47:1041-1050.
9. Herbrecht R., Letscher-Bru V., Oprea C., Lioure B., Waller J., Campos F., Villard O., Liu K.L., Natarajan-Ame S., Lutz P., Dufour P., Bergerat J.P., Candolfi E. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J. Clin. Oncol. 2002, 20:1898-1906.
10. Husain S., Paterson D.L., Studer S.M., Crespo M., Pilewski J., Durkin M., Wheat J.L., Johnson B., McLaughlin L., Bentsen C., McCurry K.R., Singh N. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation 2007, 83:1330-1336.
11. Klont R.R., Mennink-Kersten M.A., Verweij P.E. Utility of aspergillus antigen detection in specimens other than serum specimens. Clin. Infect. Dis. 2004, 39:1467-1474.
12. Labbe A.C., Su S.H., Laverdiere M., Pepin J., Patino C., Cohen S., Kiss T., Lachance S., Sauvageau G., Busque L., Roy D.C., Roy J. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation. Biol. Blood Marrow Transplant. 2007, 13:1192-1200.
13. Leeflang M.M., Debets-Ossenkopp Y.J., Visser C.E., Scholten R.J., Hooft L., Bijlmer H.A., Reitsma J.B., Bossuyt P.M., Vandenbroucke-Grauls C.M. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane. Database Syst. Rev. 2008, 8:CD007394.
14. Levy H., Horak D.A., Tegtmeier B.R., Yokota S.B., Forman S.J. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir. Med. 1992, 86:243-248.
15. Maertens J., Maertens V., Theunissen K., Meersseman W., Meersseman P., Meers S., Verbeken E., Verhoef G., Van Eldere J., Lagrou K. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 2009, 3:3.
16. Maertens J.A., Klont R., Masson C., Theunissen K., Meersseman W., Lagrou K., Heinen C., Crepin B., Van Eldere J., Tabouret M., Donnelly J.P., Verweij P.E. Optimization of the cutoff value for the aspergillus double-sandwich enzyme immunoassay. Clin. Infect. Dis. 2007, 44:1329-1336.
17. Marr K.A., Balajee S.A., McLaughlin L., Tabouret M., Bentsen C., Walsh T.J. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J. Infect. Dis. 2004, 190:641-649.
18. Marr K.A., Carter R.A., Crippa F., Wald A., Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 2002, 34:909-917.
19. Meersseman W., Lagrou K., Maertens J., Wilmer A., Hermans G., Vanderschueren S., Spriet I., Verbeken E., Van Wijngaerden E. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am. J. Respir. Crit. Care. Med. 2008, 177:27-34.
20. Musher B., Fredricks D., Leisenring W., Balajee S.A., Smith C., Marr K.A. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J. Clin. Microbiol. 2004, 42:5517-5522.
21. Nguyen M.H., Jaber R., Leather H.L., Wingard J.R., Staley B., Wheat L.J., Cline C.L., Baz M., Rand K.H., Clancy C.J. Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts. J. Clin. Microbiol. 2007, 45:2787-2792.
22. Penack O., Rempf P., Graf B., Blau I.W., Thiel E. Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management. Ann. Oncol. 2008, 19:984-989.
23. Pfeiffer C.D., Fine J.P., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin. Infect. Dis. 2006, 42:1417-1427.
24. Rennard S.I., Basset G., Lecossier D., O'Donnell K.M., Pinkston P., Martin P.G., Crystal R.G. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 1986, 60:532-538.
25. Salonen J., Lehtonen O.P., Terasjarvi M.R., Nikoskelainen J. Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome. Scand. J. Infect. Dis. 2000, 32:485-490.
26. Sanguinetti M., Posteraro B., Pagano L., Pagliari G., Fianchi L., Mele L., La Sorda M., Franco A., Fadda G. Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J. Clin. Microbiol. 2003, 41:3922-3925.
27. Siemann M., Koch-Dorfler M. The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergillosis (IPA). Mycoses 2001, 44:266-272.
28. Verweij P.E., Latge J.P., Rijs A.J., Melchers W.J., De Pauw B.E., Hoogkamp-Korstanje J.A., Meis J.F. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J. Clin. Microbiol. 1995, 33:3150-3153.